Rise Therapeutics LLC
Rockville, MD
- UEI
- N36JMJ1DKWH6
- CAGE
- 7U7H1
- Primary NAICS
- 325412 Pharmaceutical Preparation Manufacturing
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Partnership or Limited Liability Partnership
- NAICS codes registered in SAM.gov
- SAM.gov registration date
- Physical address
- 1405 Research Blvd #220, Rockville, MD 20850, USA
- Website
- risetherapeutics.com
- Employees
- 1-10
- Estimated annual revenue
- $1M-$10M
- Industry
-
- Health Care
- Pharmaceuticals, Biotechnology & Life Sciences
- Pharmaceuticals
- SIC code
- 28 Chemical & Allied Products
- Profiles
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Recent federal awards
About Rise Therapeutics LLC
Rise Therapeutics LLC is a biotechnology company based in Rockville, Maryland, registered in the System for Award Management (SAM) since 2017. The company appears to be a small business focused on developing innovative microbiome-based and synthetic biology therapeutics that leverage probiotic technologies to address various autoimmune and inflammatory diseases. As a for-profit organization and manufacturer of goods, Rise Therapeutics specializes in developing novel immunological-directed probiotics and live biotherapeutic products that aim to modulate the immune system through targeted microbiome interventions.
The company has received multiple federal grant awards from various National Institutes of Health (NIH) agencies, including the National Institute of Dental and Craniofacial Research, National Institute of Diabetes and Digestive and Kidney Diseases, National Institute of Allergy and Infectious Diseases, National Cancer Institute, and National Institute of Aging. These grants support the development of targeted therapeutic approaches for diseases such as Sjogren's syndrome, ulcerative colitis, rheumatoid arthritis, type 1 diabetes, multiple sclerosis, and viral-induced acute respiratory distress syndrome. Rise Therapeutics' primary technological approach involves engineering Lactococcus lactis probiotics to express specific proteins or enzymes that can stimulate regulatory T-cells, engage pattern recognition receptors, and modulate immune responses. The company's research focuses on creating oral immunotherapies that can potentially provide long-term disease management by resetting immune system responses and leveraging the gut microbiome's natural immunoregulatory mechanisms.
Quick answers
What is Rise Therapeutics LLC's UEI?
Rise Therapeutics LLC's Unique Entity ID (UEI) in SAM.gov is N36JMJ1DKWH6.
What is Rise Therapeutics LLC's CAGE code?
Rise Therapeutics LLC's CAGE code is 7U7H1.
What is Rise Therapeutics LLC's primary NAICS code?
Rise Therapeutics LLC's primary NAICS code is 325412 (Pharmaceutical Preparation Manufacturing).
Where is Rise Therapeutics LLC located?
Rise Therapeutics LLC's physical address in SAM.gov is 1405 Research Blvd #220, Rockville, MD 20850, USA.
Is Rise Therapeutics LLC registered in SAM.gov?
Yes. Rise Therapeutics LLC's SAM.gov registration is active through December 25, 2026.
What is Rise Therapeutics LLC's most recent federal award?
Rise Therapeutics LLC's most recent federal grant award is A novel immunological-directed live biotherapy product for treating crohn's disease - project summary the goal of this… (R44DK146369), from National Institute of Diabetes and Digestive and Kidney Diseases, on September 1, 2026.
On GovTribe
See Rise Therapeutics LLC's full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors